Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia
University of California San Diego · Centre National de la Recherche Scientifique · +3 more institutions
Abstract
Despite the clinical success of photodynamic therapy (PDT), the application of this medical technique is intrinsically limited by the low oxygen concentrations found in cancer tumors, hampering the production of therapeutically necessary singlet oxygen (1O2). To overcome this limitation, we report on a novel mitochondria-localized iridium(III) endoperoxide prodrug (2-O-IrAn), which, upon two-photon irradiation in NIR, synergistically releases a highly cytotoxic iridium(III) complex (2-IrAn), singlet oxygen, and an alkoxy radical. 2-O-IrAn was found to be highly (photo-)toxic in hypoxic tumor cells and multicellular tumor spheroids (MCTS) in the nanomolar range. To provide cancer selectivity and improve the…
Citation impact
- FWCI
- 18.14
- Percentile
- 100%
- References
- 71
Authors
9Topics & keywords
- Singlet oxygen
- Photodynamic therapy
- Chemistry
- Iridium
- Prodrug
- Photosensitizer
- Reactive oxygen species
- Mitochondrion
- Good health and well-being